Vietnam allows foreign firm to import drugs for first time
The license has somewhat shown Vietnam’s relaxed management of drugs market which is likely to reach US$7.7 billion by 2021.
France-based Sanofi-Aventis Vietnam Co., Ltd has been licensed to directly import drugs to Vietnam, becoming the first foreign-invested firm eligible to get such right in the country.
With this license, Sanofi directly imported the first batch of meningococcal meningitis vaccines, Vietnam Investment Review reported.
The move, which somewhat shows Vietnam's relaxed regulations on this sector after the country signed the EU-Vietnam Free Trade Agreement (EVFTA), is expected to draw more foreign investment in the lucrative local pharmaceutical industry while increasing access to qualified drugs among locals.
However, some concerns have been raised on the possible pressure on local pharmaceutical firms once the import duty on drugs is reduced when the EVFTA comes into force.
.
Sanofi Vietnam, which is said to hold about 4% of the Vietnamese pharmaceutical market, has three factories in the country, supplying 80% of its products sold in Vietnam.
Before, foreign-invested pharmaceutical companies were allowed to provide only warehouse and logistics services for pharmaceutical products while domestic companies are eligible to distribute pharmaceutical products.
The restrictions have forced foreign-invested enterprises to partner with local firms for the distribution.
Vietnam’s pharmaceutical industry
The Ministry of Health’s Drug Administration predicted that the country’s pharmacy sector would maintain a double-digit growth rate in the next five years.
The 2018 Business Monitor International report showed that Vietnam’s healthcare market had a value of US$17.4 billion in 2018. Meanwhile, the country’s pharmaceutical market had an estimated a revenue of US$5.9 billion in 2018, an 11.7% increase from the previous year.
In addition, at a per capita level, spending is expected to double from US$170 in 2017 to US$400 in 2027.
The average spending on medicine of Vietnamese people rose from US$22.25 in 2010 to US$37.97 in 2015, and doubled to US$56 in 2017. The average growth rate of spending on drugs was 14.6% during 2010-2015 and is set to remain at least 14% until 2025.
The figures make Vietnam the second largest medicine market in the South East Asia.
Vietnamese drugs manufacturers are able to meet half of the total medicines market demand, while imports cover the remaining half.
In addition, approximately 60% of pharmaceutical end products, 90% of active pharmaceutical ingredients, and most raw materials for the production of pharmaceuticals are currently imported, the British Business Group Vietnam quoted "EY Life science report: Asia".
In recent years, the authorities have stepped up their efforts to reduce the country’s reliance on imports. As part of their 2020 strategy, authorities intend to have 80% of domestic pharmaceutical demand met by local drug manufacturers through measures such as tendering preferences.
Vietnam's pharmaceutical trade forecast. Photo: British Business Group Vietnam
|
With this license, Sanofi directly imported the first batch of meningococcal meningitis vaccines, Vietnam Investment Review reported.
The move, which somewhat shows Vietnam's relaxed regulations on this sector after the country signed the EU-Vietnam Free Trade Agreement (EVFTA), is expected to draw more foreign investment in the lucrative local pharmaceutical industry while increasing access to qualified drugs among locals.
However, some concerns have been raised on the possible pressure on local pharmaceutical firms once the import duty on drugs is reduced when the EVFTA comes into force.
.
Drug spending per capital in Vietnam. Photo: British Business Group Vietnam
|
Sanofi Vietnam, which is said to hold about 4% of the Vietnamese pharmaceutical market, has three factories in the country, supplying 80% of its products sold in Vietnam.
Before, foreign-invested pharmaceutical companies were allowed to provide only warehouse and logistics services for pharmaceutical products while domestic companies are eligible to distribute pharmaceutical products.
The restrictions have forced foreign-invested enterprises to partner with local firms for the distribution.
Vietnam’s pharmaceutical industry
The Ministry of Health’s Drug Administration predicted that the country’s pharmacy sector would maintain a double-digit growth rate in the next five years.
The 2018 Business Monitor International report showed that Vietnam’s healthcare market had a value of US$17.4 billion in 2018. Meanwhile, the country’s pharmaceutical market had an estimated a revenue of US$5.9 billion in 2018, an 11.7% increase from the previous year.
In addition, at a per capita level, spending is expected to double from US$170 in 2017 to US$400 in 2027.
The average spending on medicine of Vietnamese people rose from US$22.25 in 2010 to US$37.97 in 2015, and doubled to US$56 in 2017. The average growth rate of spending on drugs was 14.6% during 2010-2015 and is set to remain at least 14% until 2025.
The figures make Vietnam the second largest medicine market in the South East Asia.
Vietnamese drugs manufacturers are able to meet half of the total medicines market demand, while imports cover the remaining half.
In addition, approximately 60% of pharmaceutical end products, 90% of active pharmaceutical ingredients, and most raw materials for the production of pharmaceuticals are currently imported, the British Business Group Vietnam quoted "EY Life science report: Asia".
In recent years, the authorities have stepped up their efforts to reduce the country’s reliance on imports. As part of their 2020 strategy, authorities intend to have 80% of domestic pharmaceutical demand met by local drug manufacturers through measures such as tendering preferences.
23:29, 2024/12/13
Electronic health records in Hanoi hospitals: For convenience of patients
The electronic health record is designed to increase public confidence in digital services, deliver significant cost savings and streamline procedures for citizens while promoting convenience and transparency.
10:53, 2024/12/09
Hanoi to ensure medicine supply during Tet holiday
Plans are being drawn up to stockpile medicines in hospitals and a disease control center in Hanoi.
17:20, 2024/11/29
Policy framework needed for promotion of teacher role in Vietnam
The Law on Teachers has been submitted to the National Assembly for review and initial comments by the Vietnamese government.
22:01, 2024/11/26
Hanoi attracts talent for development
The Capital Law is expected to make Hanoi an attractive destination for talented people at home and abroad.
15:08, 2024/11/16
Hanoi warns against mukbang trend of eating raw and unfamiliar foods
A communication campaign has been in place for the dissemination of information on food safety regulations in Hanoi.
07:12, 2024/11/12
2024 International Youth Festival attracts 3,000 local and international youth
The 2024 International Youth Festival helped Hanoi’s youth connect and promote the city's culture and tourism to international friends.
- Hanoi launches pilot project to integrate electronic health records into VNeID app
- Empowering new generation of biodiversity champions in Vietnam
- Capital Law to make Hanoi major center for quality education
- Hanoi raises road safety awareness among students
- Hanoi pilots artificial intelligence in five schools
- Modern pediatric hospital opens in Hanoi